In short: A liver function test is a group of blood markers, not a single score. ALT and AST show whether liver cells are being irritated, GGT is often raised by alcohol and fatty liver, and other markers show how well the liver is working. Results inside the ‘normal’ range do not rule out fatty liver, because lab reference ranges were set in populations that included many people with undiagnosed fatty liver. To check for scarring, doctors now use a simple calculation called FIB-4. Your GP is the right person to interpret your results.

Last reviewed: November 2026

Six blood sample tubes for laboratory testing
Photo: National Cancer Institute on Unsplash

What is on a liver function test?

In Australia, a ‘LFT’ usually reports several markers together:

MarkerWhat it mainly reflectsWorth knowing
ALT (alanine aminotransferase)Liver cell irritation or damageThe most liver-specific of the enzymes. Fatty liver is the most common cause of a raised ALT.
AST (aspartate aminotransferase)Liver cell damage, but also muscleCan rise after hard exercise or muscle injury. Used in the FIB-4 score.
GGT (gamma-glutamyl transferase)Liver and bile ductsOften raised by regular drinking, fatty liver and some medicines.
ALP (alkaline phosphatase)Bile ducts and boneCan be higher in growing teenagers, pregnancy and some bone conditions.
BilirubinHow well the liver clears a yellow pigment from old red blood cellsA mild isolated rise is common and often harmless (Gilbert’s syndrome), but needs a doctor’s assessment.
AlbuminA protein the liver makesLow levels can reflect reduced liver function, but also poor nutrition or other illness.

Why ‘normal’ is not always normal

Each laboratory sets its own reference range. For ALT, upper limits used by different labs have been reported to range from about 31 to 72 U/L. Those ranges were usually based on large groups of apparently healthy people, which inevitably included many with undiagnosed fatty liver.

When researchers built reference ranges only from people with no liver risk factors, the upper limits came out much lower. A well-known Italian study of blood donors proposed about 30 U/L for men and 19 U/L for women, and studies in Japanese and Chinese populations have reached similar figures. A large study of South Korean adults with ultrasound-diagnosed fatty liver concluded that a normal ALT does not guarantee the absence of liver disease.

In practice, that means:

Things that can push results up temporarily

That is why doctors often repeat a mildly abnormal result rather than acting on one test.

FIB-4: checking for scarring

The most important question with fatty liver is not how much fat there is, but whether scarring (fibrosis) has developed. Scarring is what drives the risk of cirrhosis and liver cancer.

Liver guidelines now recommend a simple first step called the Fibrosis-4 index (FIB-4). It uses four numbers that are often already on your blood test results:

FIB-4 = (age × AST) ÷ (platelet count × √ALT)

Typical cut-offs used for fatty liver are:

FIB-4 has limits. It is less reliable in people under 35, the higher cut-off is needed for older adults because age is part of the formula, and conditions such as acute hepatitis or heavy recent drinking can distort it. Different cut-offs are used for viral hepatitis. It is a triage tool for your doctor, not a diagnosis.

What to ask your GP

The bottom line

Liver blood tests are useful, but a single result inside the normal range does not prove a healthy liver, and a slightly high result is not automatically serious. If you have risk factors for fatty liver, such as extra weight around the waist, diabetes, high blood pressure or abnormal cholesterol, ask your GP about a FIB-4 score. It is a free calculation from tests you may already have had. Read more in What Is MASLD?

Written by Kyle

Kyle completed Certificate III and IV in Commercial Cookery in Australia and has more than ten years of cooking experience, including full-time work in professional kitchens. He writes about Korean food and liver health using published clinical guidelines and research. More about Kyle · How we research


This article is general information, not medical advice, and cannot be used to interpret your own results. See our Medical Disclaimer and Editorial Policy.

Sources

  1. European Association for the Study of the Liver, EASD, EASO. EASL–EASD–EASO Clinical Practice Guidelines on the management of MASLD. Journal of Hepatology. 2024.
  2. Rinella ME, et al. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology. 2023.
  3. FIB-4 calculator and guidance for health professionals. liver.org.au.
  4. Utility of ALT concentration in men and women with nonalcoholic fatty liver disease: cohort study. Journal of Clinical Medicine. 2019;8(4):445.
  5. Prati D, et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Annals of Internal Medicine. 2002;137(1):1–10.